this invention concerns compounds of adamantanamines and neramexane , including their pharmaceutically - acceptable salts , diesterioisomers , and formulations for treating alzheimer &# 39 ; s related dementias , depression , aids related dementias , as antivirals , inflammatory diseases such as rheumatoid arthritis , and cerebral ischemia , hyperlipidemia , and diabetes .